相关实验视频

Updated: Jan 15, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

对于儿科肠道衰竭的家庭亲肠营养的单一中心经验

Honam Hwang¹, Dayoung Ko¹, Hee-Beom Yang²

¹Department of Pediatric Surgery, Seoul National University Children's Hospital, Seoul, Republic of Korea.

Frontiers in pediatrics

|October 13, 2025

概括

这项关于韩国儿科家庭亲肠道营养 (HPN) 的研究发现,生存率良好,但生长率低于最佳. 为了更好的儿科HPN护理,需要改善支持,政策和营养.

科学领域:

儿科胃肠病学儿科胃肠病学
临床营养学临床营养学
父母肠道营养是一种营养.

背景情况:

儿童的肠衰竭 (IF) 通常需要家庭上肠营养 (HPN).
韩国儿科HPN计划的数据有限.
这项研究报告了韩国单一中心儿科HPN的经验.

研究的目的:

描述在韩国接受HPN的儿科患者的特征和结果.
为了确定IF的常见原因,并发症,以及这一群体的生长模式.
为改善韩国儿科HPN护理提供见解.

主要方法:

对40名儿科患者进行HPN (2009-2021) 的回顾性研究.
收集的数据包括人口统计,诊断,HPN协议,并发症 (CRBSI,IFALD),住院和增长.
随访时间中位数为53.5个月.

主要成果:

常见的IF原因:慢性肠道伪阻塞综合征 (45.0%) 和短肠综合征 (22.5%).
并发症:与导管相关的血流感染 (CRBSI) 在60.0%,与肠道衰竭相关的肝病 (IFALD) 在45.0%.
观察到低于最佳的生长率;15.0%的患者已经断绝了HPN. 没有报告死亡率.

结论:

韩国的儿科HPN显示出有利的生存率和并发症管理.
低断奶率和低于最佳的生长率表明需要进行系统性改进.
加强支持,法律改革和量身定制的营养对于优化韩国儿科HPN护理至关重要.

关键词:

与导管相关的血液感染.家庭亲肠道营养家庭亲肠道营养肠道衰竭是指肠道的衰竭.与肠道衰竭相关的肝病.儿科儿科儿科儿科

更多相关视频

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers

Published on: July 28, 2022

Orthotopic Small Bowel Transplantation in Rats

Orthotopic Small Bowel Transplantation in Rats

Published on: November 6, 2012

相关概念视频

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Pharmacokinetics in Pediatric Patients: Drug Distribution

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...